CER Daily Newsfeed

Blog Post

Optimizing the recipe for ‘health care spending pie’: Finding the most effective resource allocation

As health care costs continue to climb, rising 5.3 percent in 2015 and approaching 18 percent of the U.S. economy, it is more essential than ever to...
Press Release

National Pharmaceutical Council to Host Conference on Measuring Health Care Value and Impact on Patient Care

(Washington, DC, September 15, 2016)—The National Pharmaceutical Council (NPC) will bring together health care stakeholders on September 29 for a...
Blog Post

NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Assessment Framework

The National Pharmaceutical Council (NPC) today submitted comments to the Institute for Clinical and Economic Review (ICER) about ways to improve its...
Commentary and Testimony Page

NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Framework

September 12, 2016Steven D. Pearson, MD, MSc, FRCP President Institute for Clinical and Economic Review One State Street, Suite 1050 Boston, MA 02109...
Press Release

National Pharmaceutical Council to Host Conference on Measuring Health Care Value and Impact on Patient Care

(Washington, DC, September 15, 2016)—The National Pharmaceutical Council (NPC) will bring together health care stakeholders on September 29 for a...
Press Release

National Pharmaceutical Council Remains Engaged With the Institute for Clinical and Economic Review, Continuing Constructive Dialogue to Improve Value Assessment Frameworks

(Washington, DC, September 8, 2016)—The National Pharmaceutical Council (NPC) Board of Directors has agreed to renew the health policy research...
Press Release

NPC Takes Issue With ICER's Mischaracterization of Funding Sources

The National Pharmaceutical Council (NPC) takes exception to the Institute for Clinical and Economic Review’s (ICER) continued portrayal of us as an...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Commentary and Testimony Page

NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Framework

September 12, 2016Steven D. Pearson, MD, MSc, FRCP President Institute for Clinical and Economic Review One State Street, Suite 1050 Boston, MA 02109...
Commentary and Testimony Page

Thinking Differently About How We Assess Health Value

Health care stakeholders remain divided over how the value of health care treatments—especially medicines—should be assessed, and whether existing...
Commentary and Testimony Page

NPC Comments on Revised PCORI Methodology Standards

March 28, 2016Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036 Dr. Robin...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
YouTube Videos

2016 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

This one-hour webinar highlights the results of NPC's annual survey of comparative effectiveness research (CER) stakeholders and includes a panel...
YouTube Videos

Comparative Effectiveness Research and the Environment for Health Care Decision-Making

During a March 26, 2015 webinar, the National Pharmaceutical Council discussed the results of its annual stakeholder survey on comparative...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
Blog Post

Optimizing the recipe for ‘health care spending pie’: Finding the most effective resource allocation

As health care costs continue to climb, rising 5.3 percent in 2015 and approaching 18 percent of the U.S. economy, it is more essential than ever to...
Blog Post

NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Assessment Framework

The National Pharmaceutical Council (NPC) today submitted comments to the Institute for Clinical and Economic Review (ICER) about ways to improve its...
Blog Post

Moving Value Frameworks from Fledgling to Functional

Defining value in health care – especially as our health system shifts its focus from rewarding the volume of services provided to rewarding the...
Blog Post

CER Tweets of the Week: AHCJ CER Fellowships Announced; Latest Issue of JCER Published (August 8-12)

Last week, comparative effectiveness research stakeholders tweeted about the announcement of this year’s Association of Health Care Journalists CER...

Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges

This study provides an early evaluation of the CER Collaborative's training program's impact on...
Current Landscape: Value Assessment Frameworks

Current Landscape: Value Assessment Frameworks

This paper builds on Neumann and Cohen's informative comparison of value assessment frameworks...

cersurvey16

2016 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

NPC's sixth annual survey of stakeholder views on comparative effectiveness research (CER) and the...
  •  
  • 1 of 24
  • >